Cargando…
A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland
The good availability of medicines and medicine shortages have become global issues during recent years. Medicine shortages are often affected by universal determinants, but the availability of medicines is also depending on national characteristics. This commentary aims to discuss the issue of the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677871/ https://www.ncbi.nlm.nih.gov/pubmed/31172411 http://dx.doi.org/10.1007/s11096-019-00850-2 |
_version_ | 1783440971254464512 |
---|---|
author | Sarnola, Kati Linnolahti, Johanna |
author_facet | Sarnola, Kati Linnolahti, Johanna |
author_sort | Sarnola, Kati |
collection | PubMed |
description | The good availability of medicines and medicine shortages have become global issues during recent years. Medicine shortages are often affected by universal determinants, but the availability of medicines is also depending on national characteristics. This commentary aims to discuss the issue of the availability of medicines and medicine shortages in outpatient care in Finland, taking in consideration both national characteristics and global determinants that effect on the availability of medicines in other countries but Finland also. In this commentary, a regulatory approach is applied. |
format | Online Article Text |
id | pubmed-6677871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-66778712019-08-16 A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland Sarnola, Kati Linnolahti, Johanna Int J Clin Pharm Commentary The good availability of medicines and medicine shortages have become global issues during recent years. Medicine shortages are often affected by universal determinants, but the availability of medicines is also depending on national characteristics. This commentary aims to discuss the issue of the availability of medicines and medicine shortages in outpatient care in Finland, taking in consideration both national characteristics and global determinants that effect on the availability of medicines in other countries but Finland also. In this commentary, a regulatory approach is applied. Springer International Publishing 2019-06-07 2019 /pmc/articles/PMC6677871/ /pubmed/31172411 http://dx.doi.org/10.1007/s11096-019-00850-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Commentary Sarnola, Kati Linnolahti, Johanna A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland |
title | A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland |
title_full | A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland |
title_fullStr | A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland |
title_full_unstemmed | A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland |
title_short | A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland |
title_sort | regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case finland |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677871/ https://www.ncbi.nlm.nih.gov/pubmed/31172411 http://dx.doi.org/10.1007/s11096-019-00850-2 |
work_keys_str_mv | AT sarnolakati aregulatoryperspectiveontheavailabilityofmedicinesandmedicineshortagesinoutpatientcarecasefinland AT linnolahtijohanna aregulatoryperspectiveontheavailabilityofmedicinesandmedicineshortagesinoutpatientcarecasefinland AT sarnolakati regulatoryperspectiveontheavailabilityofmedicinesandmedicineshortagesinoutpatientcarecasefinland AT linnolahtijohanna regulatoryperspectiveontheavailabilityofmedicinesandmedicineshortagesinoutpatientcarecasefinland |